Finally, in two independent clinical cohorts of melanoma patients, retention of high RARRES2 (a gene encoding the chemoattractant chemerin) expression correlated with better clinical outcomes (Pachynski et al., 2012). This evidence concerns the gene RARRES2 and melanoma.